Expanding upon the relationship between gender-affirming hormone therapy, neural connectivity, mental health, and body image dissatisfaction.
Autor: | Grannis C; Center for Biobehavioral Health, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH, USA. Electronic address: Connor.Grannis@NationwideChildrens.org., Mattson WI; Center for Biobehavioral Health, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH, USA., Leibowitz SF; Department of Psychiatry and Behavioral Health, Nationwide Children's Hospital, Columbus, OH, USA., Nahata L; Center for Biobehavioral Health, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH, USA; Department of Endocrinology, Nationwide Children's Hospital, Columbus, OH, USA; Department of Pediatrics, Ohio State University Wexner College of Medicine, Columbus, OH, USA., Chen D; Pritzker Department of Psychiatry and Behavioral Health, and Potocsnak Family Division of Adolescent and Young Adult Medicine, Ann & Robert H. Lurie Children's Hospital, Chicago, IL, USA; Departments of Psychiatry and Behavioral Sciences, and Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Strang JF; Gender Development Program and Division of Pediatric Neuropsychology, Children's National Research Institute at Children's National Hospital, Washington, DC, USA., Thobe H; Department of Psychiatry and Behavioral Health, Nationwide Children's Hospital, Columbus, OH, USA., Indyk JA; Department of Endocrinology, Nationwide Children's Hospital, Columbus, OH, USA., Nelson EE; Center for Biobehavioral Health, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH, USA; Department of Pediatrics, Ohio State University Wexner College of Medicine, Columbus, OH, USA. |
---|---|
Jazyk: | angličtina |
Zdroj: | Psychoneuroendocrinology [Psychoneuroendocrinology] 2023 Oct; Vol. 156, pp. 106319. Date of Electronic Publication: 2023 Jun 08. |
DOI: | 10.1016/j.psyneuen.2023.106319 |
Abstrakt: | Objective: Transgender/non-binary (TNB) youth are at increased risk for anxiety, depression, and suicidality compared to cisgender youth. Gender affirming hormone therapy (GAHT, i.e., testosterone or estrogen) is a standard of care option for TNB youth, and we have recently shown that GAHT (testosterone) in transgender youth assigned a female sex at birth is associated with reductions in internalizing symptomatology. The current analysis explores: 1) whether these benefits are observed in both TNB youth assigned female at birth (TNB Method: The current study is an expansion of a previous publication from our lab that explored the association between gender-affirming testosterone and internalizing symptomatology. While participants in our previous study consisted of 42 TNB Results: GAHT+ TNB Conclusion: The current study suggests that GAHT is associated with fewer short-term internalizing symptoms in TNB Competing Interests: Declaration of Competing Interest none. (Copyright © 2023 Elsevier Ltd. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |